Cargando…
Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial
BACKGROUND: Asthma is a frequent diagnosis in competitive sports, and inhaled β(2)-agonists are commonly used by athletes. Although inhaled β(2)-agonists do not seem to improve performance in athletes, it has remained uncertain whether they can increase exercise performance in non-athletes. OBJECTIV...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135409/ https://www.ncbi.nlm.nih.gov/pubmed/30233808 http://dx.doi.org/10.1136/bmjsem-2018-000397 |
_version_ | 1783354816544636928 |
---|---|
author | Eckerström, Filip Rex, Christian Emil Maagaard, Marie Rubak, Sune Hjortdal, Vibeke Elisabeth Heiberg, Johan |
author_facet | Eckerström, Filip Rex, Christian Emil Maagaard, Marie Rubak, Sune Hjortdal, Vibeke Elisabeth Heiberg, Johan |
author_sort | Eckerström, Filip |
collection | PubMed |
description | BACKGROUND: Asthma is a frequent diagnosis in competitive sports, and inhaled β(2)-agonists are commonly used by athletes. Although inhaled β(2)-agonists do not seem to improve performance in athletes, it has remained uncertain whether they can increase exercise performance in non-athletes. OBJECTIVE: To investigate the effect of inhaled β(2)-agonists on exercise performance in healthy non-athlete individuals. METHODS: In a double-blinded, placebo-controlled, cross-over trial, healthy, non-asthmatic, non-athlete individuals were randomised to inhalation of either 900 µg of salbutamol or placebo. Cardiopulmonary exercise testing, dynamic spirometry and impulse oscillometry were performed. The primary outcome was the effect from salbutamol on peak oxygen uptake, whereas secondary outcomes were breathing reserve and ventilation efficiency, and workload, heart rate, breath rate and minute ventilation at peak exercise under influence of salbutamol. RESULTS: A total of 36 healthy subjects with a mean age of 26±5 years were included. Salbutamol had no effect on peak oxygen uptake compared with placebo, 46.8±1.3 mL/kg/min versus 46.6±1.2 mL/kg/min, p=0.64. Salbutamol had no effect on workload, p=0.20, heart rate, p=0.23, breath rate, p=0.10, or minute ventilation, p=0.26, at peak exercise compared with placebo. Salbutamol lowered oxygen uptake, p=0.04, and workload, p=0.04, at anaerobic threshold compared with placebo. Forced expiratory volume in 1 s, 116%±13% of predicted, and peak expiratory flow, 122%±16% of predicted, increased after inhalation of salbutamol compared with placebo; 109%±13% and 117%±17%, respectively, p<0.01. Breathing reserve was found to be higher, 22%±2%, after salbutamol inhalation than after placebo, 16%±2%, p<0.01. CONCLUSION: Inhaled salbutamol did not improve peak oxygen uptake in healthy, non-asthmatic, non-athlete individuals compared with placebo. TRIAL REGISTRATION NUMBER: NCT02914652. |
format | Online Article Text |
id | pubmed-6135409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-61354092018-09-19 Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial Eckerström, Filip Rex, Christian Emil Maagaard, Marie Rubak, Sune Hjortdal, Vibeke Elisabeth Heiberg, Johan BMJ Open Sport Exerc Med Original Article BACKGROUND: Asthma is a frequent diagnosis in competitive sports, and inhaled β(2)-agonists are commonly used by athletes. Although inhaled β(2)-agonists do not seem to improve performance in athletes, it has remained uncertain whether they can increase exercise performance in non-athletes. OBJECTIVE: To investigate the effect of inhaled β(2)-agonists on exercise performance in healthy non-athlete individuals. METHODS: In a double-blinded, placebo-controlled, cross-over trial, healthy, non-asthmatic, non-athlete individuals were randomised to inhalation of either 900 µg of salbutamol or placebo. Cardiopulmonary exercise testing, dynamic spirometry and impulse oscillometry were performed. The primary outcome was the effect from salbutamol on peak oxygen uptake, whereas secondary outcomes were breathing reserve and ventilation efficiency, and workload, heart rate, breath rate and minute ventilation at peak exercise under influence of salbutamol. RESULTS: A total of 36 healthy subjects with a mean age of 26±5 years were included. Salbutamol had no effect on peak oxygen uptake compared with placebo, 46.8±1.3 mL/kg/min versus 46.6±1.2 mL/kg/min, p=0.64. Salbutamol had no effect on workload, p=0.20, heart rate, p=0.23, breath rate, p=0.10, or minute ventilation, p=0.26, at peak exercise compared with placebo. Salbutamol lowered oxygen uptake, p=0.04, and workload, p=0.04, at anaerobic threshold compared with placebo. Forced expiratory volume in 1 s, 116%±13% of predicted, and peak expiratory flow, 122%±16% of predicted, increased after inhalation of salbutamol compared with placebo; 109%±13% and 117%±17%, respectively, p<0.01. Breathing reserve was found to be higher, 22%±2%, after salbutamol inhalation than after placebo, 16%±2%, p<0.01. CONCLUSION: Inhaled salbutamol did not improve peak oxygen uptake in healthy, non-asthmatic, non-athlete individuals compared with placebo. TRIAL REGISTRATION NUMBER: NCT02914652. BMJ Publishing Group 2018-08-30 /pmc/articles/PMC6135409/ /pubmed/30233808 http://dx.doi.org/10.1136/bmjsem-2018-000397 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Original Article Eckerström, Filip Rex, Christian Emil Maagaard, Marie Rubak, Sune Hjortdal, Vibeke Elisabeth Heiberg, Johan Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
title | Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
title_full | Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
title_fullStr | Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
title_full_unstemmed | Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
title_short | Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
title_sort | exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135409/ https://www.ncbi.nlm.nih.gov/pubmed/30233808 http://dx.doi.org/10.1136/bmjsem-2018-000397 |
work_keys_str_mv | AT eckerstromfilip exerciseperformanceaftersalbutamolinhalationinnonasthmaticnonathleteindividualsarandomisedcontrolledcrossovertrial AT rexchristianemil exerciseperformanceaftersalbutamolinhalationinnonasthmaticnonathleteindividualsarandomisedcontrolledcrossovertrial AT maagaardmarie exerciseperformanceaftersalbutamolinhalationinnonasthmaticnonathleteindividualsarandomisedcontrolledcrossovertrial AT rubaksune exerciseperformanceaftersalbutamolinhalationinnonasthmaticnonathleteindividualsarandomisedcontrolledcrossovertrial AT hjortdalvibekeelisabeth exerciseperformanceaftersalbutamolinhalationinnonasthmaticnonathleteindividualsarandomisedcontrolledcrossovertrial AT heibergjohan exerciseperformanceaftersalbutamolinhalationinnonasthmaticnonathleteindividualsarandomisedcontrolledcrossovertrial |